Moderna Files FDA Application for the JN.1 Targeting COVID-19 …
Jun 7, 2024 · Manufacturing is underway and doses of Moderna's Spikevax 2024-2025 formula will be ready to ship as early as August, pending regulatory approval CAMBRIDGE, MA / ACCESSWIRE / June 7, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its Spikevax 2024-2025 formula, targeting the SARS-CoV-2 variant ...
Moderna Receives U.S. FDA Approval for Updated COVID-19 …
Sep 11, 2023 · Moderna's updated COVID-19 vaccine contains spike proteins for the XBB.1.5 sublineage of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older. With the U.S. FDA's decision, Moderna will begin shipping doses to vaccination sites across the U.S., with updated vaccines expected to be available in the coming days.
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
FDA approved and authorized for emergency use updated mRNA COVID-19 vaccines (2024-2025 formula) to more closely target currently circulating variants to prevent COVID-19 and to provide...
What to Know About the Updated 2024-2025 COVID Vaccines
Oct 24, 2024 · Pfizer’s and Moderna’s updated mRNA vaccines were fully approved in the middle of August for everyone ages 12 and older, and each has a Food and Drug Administration (FDA) emergency use authorization (EUA) for infants and children ages 6 months through 11 years. The mRNA vaccines target a SARS-CoV-2 strain called KP.2.
Moderna Clinical Trial Data Confirm Its Updated Covid-19 Vaccine ...
Sep 6, 2023 · Clinical trial data from research assay confirmed Moderna's updated COVID-19 vaccine showed an 8.7 to 11-fold increase in neutralizing antibodies against circulating variants, including BA.2.86, EG.5, and FL.1.5.1 variants.
FDA Takes Action on Updated mRNA COVID-19 Vaccines to …
FDA approved and authorized for emergency use updated COVID-19 vaccines formulated to more closely target currently circulating variants and to provide better protection against serious ...
Celebrating U.S. FDA Approval of Our Updated COVID-19 Vaccine - Moderna
I am pleased to announce that the U.S. Food and Drug Administration (FDA) has approved Moderna’s updated COVID-19 vaccine for this fall for individuals 12 years of age and older. The updated vaccine composition targets the KP.2 variant, based on guidance from the U.S. FDA.
Novavax COVID shots offer a third option, along with Pfizer and Moderna …
Aug 22, 2024 · The Food and Drug Administration has greenlighted three updated vaccines — the Pfizer-BioNTech and Moderna shots, and now a third one from Novavax, which was just authorized by the FDA on Friday.
The Moderna COVID-19 (mRNA-1273) vaccine: what you need …
Aug 18, 2022 · The Moderna vaccine after two doses and a first booster dose has been shown to have very high effectiveness against severe disease, hospitalizations and death, and modest effectiveness against symptomatic illness.
Moderna Bivalent COVID-19 Vaccine More Effective at Preventing ...
5 days ago · Moderna's mRNA-1273.222 vaccine showed higher effectiveness than Pfizer-BioNTech's BNT162b2 in preventing COVID-19-related hospitalizations and outpatient encounters. The study included over 1.9 million adults, with mRNA-1273.222 showing a 10.9% rVE against hospitalization and 3.2% against outpatient encounters.